Implementing IntelliCare in Collaborative Care: A Quality Improvement Evaluation

Not Applicable

Terminated

• Conditions: Depression
• Interventions: Behavioral: Treatment as Usual (TAU); Device: IntelliCare

• Registration Number: NCT04499729
• Lead Sponsor: Adaptive Health, Inc

Brief Summary

The overarching aim of the proposed project is to conduct a pragmatic, quality improvement evaluation of the IntelliCare Platform for improving processes of care in the Rush Collaborative Care program, and improving patient population depression outcomes, to determine the long-term utility of IntelliCare for Rush.

Detailed Description

This study is a pragmatic, system-wide rollout quality improvement evaluation design displayed in Figure 1. The Rush IRB has waived consent for this quality improvement trial. Data from the EHR will be used beginning December 1, 2019. The first care manager (CM) will begin enrolling patients into IntelliCare in September, 2020. Additional CMs will begin using IntelliCare at approximately 3 month intervals. In September 2021, support for IntelliCare from the evaluation team will be withdrawn, to examine the sustainability of the IntelliCare Platform.

Patients Data from all patients, aged 18 or older, enrolled collaborative care from December 1, 2019 through August 31, 2022 will be used to evaluate the IntelliCare service. All CCT patients who are 18 or older, and have a smartphone will be offered enrollment.

Study Timeline

• Study Start: 2019-12-01
• Study First Submitted: 2020-07-27
• Study First Submitted QC: 2020-07-31
• Study First Posted: 2020-08-05
• Primary Completion: 2021-05-01
• Study Completion: 2021-05-01
• Status Verified: 2021-11
• Last Update Submitted: 2021-11-22
• Last Update Posted: 2021-12-03

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 318

Inclusion Criteria

• Enrolled in Rush Collaborative Care service
• Owns a personal smartphone

Exclusion Criteria

• None

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Treatment as Usual (TAU)	Treatment as Usual (TAU)	TAU will be the treatment that is provided through the Rush Collaborative Care program as part of their service
IntelliCare	IntelliCare	Patients will be offered IntelliCare as part of their care in the Rush Collaborative Care service. Patients who agree will download the IntelliCare app, which provides self management and collects symptom self-report data. Symptom severity scores are displayed to the care manager, allowing them to manage the patient's care. The app also provides a secure messaging service for communication between the care manager and the patient.

Primary Outcome Measures

Name	Time	Method
Depression	Up to 20 Months	Patient Health Questionnaire-9 (PHQ-9) assessment for depression
Number of assessments	Up to 20 Months	Number of Patient Health Questionnaire (PHQ-9) assessments acquired in the EHR

Secondary Outcome Measures

Name	Time	Method
First to last assessment	Up to 20 Months	Time from first to last PHQ-9

Trial Locations

Locations (1)

Rush University Medical Center; 🇺🇸 Chicago, Illinois, United States